The Zacks analyst believes that lower realized prices in the Unites States, loss of exclusivity for products in hormone replacement therapy and intensifying competition will impact sales.The Zacks analyst believes that strength in defense and space businesses as well as solid demand for its warehouse automation products will likely boost Honeywellâ€™s revenues in the quarters ahead.